EUVIMEDEUVIMED entdecken
Übersichtsarbeit

mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes

Natalia Bobok

Aging · 11.02.2026 · 18 (1) · 1280-1315

DOI: 10.18632/aging.206423 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging, online erschienen am 19.09.2026. Verfasst von Natalia Bobok. Beteiligte Einrichtung: Chief Scientific Officer, INSTYTUTUM AG, Zug 6300, Switzerland. Hauptthemen laut MEDLINE: Aging, Signal Transduction, TOR Serine-Threonine Kinases. Die Arbeit nennt 265 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic target of rapamycin (mTOR) pathway is an important integrator of processes involved in aging and longevity, coordinating nutrient sensing, metabolic adaptation, and cellular stress responses. This review presents a three-section framework in which mTOR functions as a dynamic signaling hub coordinating multiple biological processes underlying the aging process. Evidence from genetic, experimental, and translational studies supports a causal role for mTOR signaling in lifespan regulation in model organisms, whereas human data remain predominantly associative but biologically consistent. mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) regulate distinct yet complementary aspects of cellular metabolism, proteostasis, autophagy, stress adaptation, and tissue homeostasis. Major geroprotective interventions-including autophagy activation, dietary interventions, physical activity, and senotherapeutics-partly converge on mTOR signaling but also engage parallel pathways. This adaptive regulation restores anabolic-catabolic balance, enhances stress resilience, and improves metabolic flexibility. Collectively, the available evidence identifies mTOR as an important integrative node linking multiple hallmarks of aging and diverse geroprotective interventions. Rather than representing a single therapeutic target, mTOR should be viewed as a context-dependent signaling hub which precise, tissue-specific modulation may promote healthy aging and support future geroscience-based interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingSignal TransductionTOR Serine-Threonine KinasesHumansAnimalsLongevityAutophagy

Stichwörter der Autor:innen

geroprotective interventionshallmarks of agingmTOR signalingmTORC1mTORC2

Substanzen

TOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Chief Scientific Officer, INSTYTUTUM AG, Zug 6300, Switzerland.

Zitieren

APA

Bobok, N. (2026). mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes. Aging, 18(1), 1280-1315. https://doi.org/10.18632/aging.206423

Vancouver

Bobok N. mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes. Aging. 2026;18(1):1280-1315. doi:10.18632/aging.206423

BibTeX
@article{Bobok2026,
  author = {Bobok, Natalia},
  title = {mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes},
  journal = {Aging},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {1280--1315},
  doi = {10.18632/aging.206423}
}
Kostenlos starten →